- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT04048772
CALM IVF (Tworzenie przynależności, nauka i uważność dla pacjentów z zapłodnieniem in vitro)
Tworzenie przynależności, uczenia się i uważności dla pacjentów z zapłodnieniem in vitro
The investigators have designed a psychoeducational group curriculum specifically for new in vitro fertilization (IVF) patients (both male and female) to improve their treatment knowledge, to allow them to engage more in their care, to offer a support network, to improve satisfaction, and to provide them with tools to help reduce their stress and anxiety while undergoing the IVF process. The investigators plan to have four to eight infertility patients and their partners participate in a group at a time, for which they will attend three 1-1.5 hour interactive sessions that are scheduled throughout their first IVF cycle. These sessions will provide additional time for discussion about treatment with providers, learning opportunities on topics of interest to fertility patients, and stress reduction techniques. They will do several surveys before and after the intervention for comparison, including assessment of quality of life, depression, anxiety, resilience, and a knowledge assessment. The investigators will also track the patients to see if they pursue additional treatment in the instance of a negative pregnancy test compared to patients undergoing the standard treatment. The investigators plan to recruit a control group that receives the standard of care treatment here at the University of Iowa.
Przegląd badań
Status
Warunki
Interwencja / Leczenie
Szczegółowy opis
Patients and their partners (if present and consenting) will be randomized in a 2:1 fashion to two different treatment arms: A) standard of care in vitro fertilization (IVF) at the investigational institution as well as participating in an additional psychoeducational group or B) standard of care IVF at the investigational institution. The intervention group will consist of three additional evening visits for 1-1.5 hours per session. The sessions will include an interactive educational component addressing usual questions and concerns of IVF patients, such as reviewing common IVF myths, and also more information regarding treatment and technologies. Each session will also include teaching of coping strategies (such as awaiting the pregnancy test, how to cope with insensitive remarks from friends and family) as well as relaxation exercises, such as progressive muscle relaxation and deep breathing.
The patients will be consented at their new IVF visit and will take their initial assessments (FertiQoL, GAD-7, PHQ-9, the Connor-Davidson Resilience Scale, and a knowledge assessment) within 24 hours of the new visit. The patients will be assigned into groups based on when they are going through their IVF stimulations, so they will have similar experiences at similar times. Patients will take their final assessments on the third day after egg retrieval, regardless of group assignment.
When partners are present and consent to the study, they will be treated as a dyad with the patient undergoing oocyte retrieval. Some patients go through treatment alone (i.e. single adults desiring pregnancy) and therefore may not have a partner available to participate. Partners level of involvement in a cycle may very, as may their desire to participate in a psychosocial intervention. As patients and their partners make joint decisions throughout their IVF cycle and the cycle itself has a single outcome, we enrolled partners as dyads with patients when partners were present, but did not require a partner to enroll a patient.
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
Iowa
-
Iowa City, Iowa, Stany Zjednoczone, 52242
- University of Iowa Hospitals and Clinics
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- All patients starting their first in vitro fertilization cycle at the University of Iowa Hospitals and Clinics
Exclusion Criteria:
- Patients who have already undergone in vitro fertilization treatment at any institution
- Non-English speakers
- Fertility preservation patients
- Patients using donor oocytes, embryos, or sperm
- Patients taking psychotropic medications for depression or anxiety that have had a dosing adjustment within 3 months of study enrollment
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie podtrzymujące
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Brak (otwarta etykieta)
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Eksperymentalny: Intervention
Standard of care in vitro fertilization patients randomized to the psychoeducational group intervention. |
The intervention will be three 1-1.5 hour interactive sessions that are scheduled throughout the participant's first in vitro fertilization cycle. These sessions will provide additional time for discussion about treatment with providers, learning opportunities on topics of interest to fertility patients, and stress reduction techniques. |
|
Inny: Control
Standard of care in vitro fertilization patients at our institution. |
Patients will receive the standard of care IVF treatment at the University of Iowa. |
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Change in female fertility patient quality of life score during IVF treatment cycle
Ramy czasowe: From enrollment to 2-4 days after oocyte retrieval
|
FertiQoL International (Fertility Quality of Life Questionnaire 2008), scored scale from 0-100, with higher values indicating a higher quality of life and low scores indicating a lower quality of life. |
From enrollment to 2-4 days after oocyte retrieval
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Change in female GAD-7 score during IVF treatment cycle
Ramy czasowe: From enrollment to 2-4 days after oocyte retrieval
|
Generalized Anxiety Disorder 7-item scale, with higher scores indicating higher likelihood of an anxiety disorder and lower scores indicating less likelihood of an anxiety disorder. |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in female PHQ-9 score during IVF treatment cycle
Ramy czasowe: From enrollment to 2-4 days after oocyte retrieval
|
Patient Health Questionnaire, with higher score indicating increased likelihood of a depressive disorder and lower scores indicating less likelihood of a depressive disorder. |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in female Connor-Davidson Resilience Scale during IVF treatment cycle
Ramy czasowe: From enrollment to 2-4 days after oocyte retrieval
|
Connor-Davidson Resilience Scale, with higher scores indicating greater resilience, and lower scores indicating lower resilience |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in female knowledge assessment during IVF treatment cycle
Ramy czasowe: From enrollment to 2-4 days after oocyte retrieval
|
Assessment of knowledge regarding IVF treatment, with higher scores indicating a greater knowledge of IVF treatment, and lower scores indicating less knowledge regarding IVF treatment |
From enrollment to 2-4 days after oocyte retrieval
|
|
Likelihood of continued IVF treatment in the instance of a negative pregnancy test
Ramy czasowe: Three months after embryo transfer
|
Patients who are not pregnant after embryo transfer will be followed for three months to assess likelihood to return for additional treatment after negative embryo transfer outcome. |
Three months after embryo transfer
|
|
Change in male fertility patient quality of life score during IVF treatment cycle
Ramy czasowe: From enrollment to 2-4 days after oocyte retrieval
|
FertiQoL International (Fertility Quality of Life Questionnaire 2008), scored scale from 0-100, with higher values indicating a higher quality of life and low scores indicating a lower quality of life. |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in male GAD-7 score during IVF treatment cycle
Ramy czasowe: From enrollment to 2-4 days after oocyte retrieval
|
Generalized Anxiety Disorder 7-item scale, with higher scores indicating higher likelihood of an anxiety disorder and lower scores indicating less likelihood of an anxiety disorder. |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in male PHQ-9 score during IVF treatment cycle
Ramy czasowe: From enrollment to 2-4 days after oocyte retrieval
|
Patient Health Questionnaire, with higher score indicating increased likelihood of a depressive disorder and lower scores indicating less likelihood of a depressive disorder. |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in male Connor-Davidson Resilience Scale during IVF treatment cycle
Ramy czasowe: From enrollment to 2-4 days after oocyte retrieval
|
Connor-Davidson Resilience Scale, with higher scores indicating greater resilience, and lower scores indicating lower resilience |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in male knowledge assessment during IVF treatment cycle
Ramy czasowe: From enrollment to 2-4 days after oocyte retrieval
|
Assessment of knowledge regarding IVF treatment, with higher scores indicating a greater knowledge of IVF treatment, and lower scores indicating less knowledge regarding IVF treatment |
From enrollment to 2-4 days after oocyte retrieval
|
Współpracownicy i badacze
Sponsor
Śledczy
- Główny śledczy: Rachel M Whynott, MD, University of Iowa
Publikacje i pomocne linki
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
- Zachowanie
- Przestrzeganie i przestrzeganie zaleceń dotyczących leczenia
- Zachowanie zdrowotne
- Akceptacja opieki zdrowotnej przez pacjentów
- Udział pacjentów
- Zadowolenie pacjenta
- Administracja usług zdrowotnych
- Jakość opieki zdrowotnej, dostęp i ocena
- Jakość opieki zdrowotnej
- Wskaźniki jakości, opieka zdrowotna
- Standard opieki
Inne numery identyfikacyjne badania
- 201906788
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .